Trademark: 79066961
Word
ARK THERAPEUTICS
Status Date
Wednesday, March 13, 2019
Registration Number
3742666
Registration Date
Tuesday, January 26, 2010
Filing Date
Friday, March 13, 2009
Published for Opposition
Tuesday, November 10, 2009
Cancellation Date
Wednesday, March 13, 2019
1 Diagnostic protein preparations for use in science, scientific diagnostics and industry; diagnostic preparations of genes for use in science, scientific diagnostics and industry
5 Pharmaceutical preparations for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting; pharmaceutical preparations for the prevention of stenosis, namely, stenosis caused by intimal hyperplasia following surgical procedures; pharmaceutical preparations to promote or suppress angiogenesis and enhance blood flow; pharmaceutical preparations for increasing the efficiency of muscle cell energy production; therapeutic agents for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting; therapeutic agents for the prevention of stenosis, namely, stenosis caused by intimal hyperplasia following surgical procedures; therapeutic agents to promote or suppress angiogenesis and enhance blood flow; therapeutic agents for increasing the efficiency of muscle cell energy production; diagnostic preparations for medical purposes; protein preparations for clinical or medical laboratory use, namely for targeting therapeutic agents to specific sites; medical dressings; surgical dressings; burn dressings; wound dressings; absorbent wound and burn dressings in the nature of pads; foot and hand dressings for medical purposes; fluid handling foot and hand dressings for medical purposes; preparations of genes for therapeutics purposes namely for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting; preparations of genes for therapeutic purposes namely for the prevention of stenosis, namely, stenosis caused by intimal hyperplasia following surgical procedures; preparations of genes for therapeutic purposes namely to promote or suppress angiogenesis and enhance blood flow; preparations of genes for therapeutic purposes namely for increasing the efficiency of muscle cell energy production
10 Boots and gloves for orthopaedic and medical purposes; boots and gloves for medical purposes with the ability to handle wound fluid; boots and gloves for medical use and absorbent filters, liners and inserts for use therewith; filters, soles and absorbent inserts for socks, boots and gloves for medical purposes, namely, for the treatment of wounds and burns; foot and hand dressings for medical purposes, namely, for the treatment of wounds and burns; parts and fittings for all the aforesaid goods
42 Scientific, medical and clinical research, all in the field of the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting, prevention of stenosis, increasing the efficiency of muscle cell energy production and promoting or suppressing angiogenesis and enhancing blood flow; scientific, medical and clinical research for the discovery, design, creation, development and testing in the field of pharmaceutical preparations and therapeutically active substances; scientific, medical and clinical research in the field of gene therapy; scientific, medical and clinical research for the discovery, design, creation, development and testing in the field of pharmaceutical preparations and therapeutically active substances for use in the field of gene therapy; advisory services relating to the aforesaid services; scientific, medical and clinical research in the field of genes and genetics; medical and scientific research, namely, conducting gene therapy trials; provision of information relating to the above
The color(s) blue and yellow is/are claimed as a feature of the mark.
"THERAPEUTICS"
The mark consists of an outer arc in the color blue and a concentric inner arc in the color yellow. To the right of the arcs appears the term "ARK" in the color blue over the term "THERAPEUTICS" also in blue.
Oct 11, 2019
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Oct 11, 2019
Death Of International Registration
Jun 16, 2017
Total Invalidation Processed By The Ib
May 11, 2017
Total Invalidation Of Reg Ext Protection Sent To Ib
May 11, 2017
Invalidation Processed
May 2, 2017
Total Invalidation Of Reg Ext Protection Created
Sep 2, 2016
Cancelled Section 71
Feb 7, 2013
Final Decision Transaction Processed By Ib
May 24, 2010
Final Disposition Notice Sent To Ib
May 24, 2010
Final Disposition Processed
Apr 26, 2010
Final Disposition Notice Created, To Be Sent To Ib
Jan 26, 2010
Registered-Principal Register
Nov 10, 2009
Published For Opposition
Oct 21, 2009
Notice Of Publication
Oct 7, 2009
Law Office Publication Review Completed
Oct 5, 2009
Approved For Pub - Principal Register
Sep 12, 2009
Amendment From Applicant Entered
Sep 12, 2009
Correspondence Received In Law Office
Sep 12, 2009
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 12, 2009
Assigned To Lie
Sep 9, 2009
Teas Response To Office Action Received
Jul 18, 2009
Refusal Processed By Ib
Jun 10, 2009
Non-Final Action Mailed - Refusal Sent To Ib
Jun 10, 2009
Refusal Processed By Mpu
Jun 10, 2009
Non-Final Action (Ib Refusal) Prepared For Review
Jun 9, 2009
Non-Final Action Written
Jun 5, 2009
Assigned To Examiner
Apr 28, 2009
Application Filing Receipt Mailed
Apr 24, 2009
New Application Office Supplied Data Entered In Tram
Apr 23, 2009
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
